3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Wounds and Injuries
1
Peripheral Nervous System Diseases
1
Neuralgia
1
Lymphoma, Follicular
1
Bronchiolitis Obliterans Syndrome
1
Interventions
tofacitinib
7
ofatumumab
4
ibrutinib
4
Rituximab
2
KW-2478
2
Dasatinib
2
Alemtuzumab
2
ziconotide
1
sodium luminolate
1
ruxolitinib
1
oblimersen
1
obinutuzumab
1
mocetinostat
1
milatuzumab
1
ixekizumab
1
fludarabine
1
fenebrutinib
1
baricitinib
1
abexinostat
1
Saline Solution
1
Lenalidomide
1
Hsp90 inhibitor KU757
1
Etanercept
1
Cyclophosphamide
1
Bortezomib
1
B3(Fv)-PE38KDEL recombinant immunotoxin
1
4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bronchiolitis Obliterans Syndrome
×
ziconotide
×
Lymphoid
×
Clear all
NCT01373983
2014-12-30
ZicBol
University Hospital, Linkoeping
Phase 4
Completed
26 enrolled